Renal cell carcinoma with rhabdoid features: An aggressive neoplasm with overexpression of p53

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 1, 2007, Pages 102-106

  Leroy, Xavier ^a   Zini, Laurent ^a   Buob, David ^a   Ballereau, Charles ^a   Villers, Arnauld ^a   Aubert, Sebastien ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; DESMIN; EPITHELIAL MEMBRANE ANTIGEN; PROTEIN P53; SMOOTH MUSCLE ACTIN; VIMENTIN;

ADULT; AGED; CANCER STAGING; CANCER SURVIVAL; CELL INCLUSION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; EOSINOPHILIA; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALE; METASTASIS; MORPHOLOGY; PROGNOSIS; REVIEW; RHABDOID TUMOR; TUMOR DIFFERENTIATION; TUMOR NECROSIS; TUMOR VOLUME;

ADULT; AGED; CA-15-3 ANTIGEN; CARCINOMA, RENAL CELL; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RHABDOID TUMOR; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; VIMENTIN;

EID: 33846615004     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Weeks DA, Beckwith JB, Mierau GW, Zuppan CW. Renal neoplasms mimicking rhabdoid tumor of kidney: a report from the national Wilms' tumor study pathology center. Am J Surg Pathol. 1991;13:1042-1054.
2. Gökden N, Napi O, Swanson PE, et al. Renal cell carcinoma with rhabdoid features. Am J Surg Pathol. 2000;24:1329-1338.
3. Kuroiwa K, Kinoshita Y, Shiratsuchi H, et al. Renal cell carcinoma with rhabdoid features: an aggressive neoplasm. Histopathohgy. 2002;41:538-548.
4. Shannon B, Wisniewski ZS, Bentel J, Cohen RJ. Adult rhabdoid renal cell carcinoma: divergent differentiation of conventional (clear cell) carcinoma. Arch Pathol Lab Med. 2002;126:1506-1510.
5. Argani P, Ladanyi M. Recent advances in pediatric neoplasia. Adv Anat Pathol. 2003;10:243-260.
6. Hofmockel G, Wittman A, Dammrich J, et al. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance. Anticancer Res. 1996;16:3807-3811.
7. Rioux-leclercq N, Turlin B, Bansard JY, et al. Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma. Urology. 2000;55:501-505.
8. Ziguener R, Ratschek M, Rehak P, Schips L, Langner C. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue. Urology. 2004;63:651-655.
9. Kim HL, Selingson D, Liu X, et al. Using protein expressions to predict survival in clear cell renal carcinoma. Clin Cancer Res. 2004;10:5464-5471.
10. Shvarts O, Selingson D, Lam J, et al. p53 is an independent predictor of tumor recurrence and progression after nephrectomy in patients with localized renal cell carcinoma. J Urol. 2005;173:725-728.
11. Castillo M, Petit A, Mellado B, Palacin A, Alcover JB, Mallofre C. C-Kit expression in sarcomatoid renal cell carcinoma: potential therapy with imatinib. J Urol. 2004;171:2176-2180.
12. Kuroda N, Satake H, Miyazaki E, Hayashi Y, Hiroi M, Enzan H. Collecting duct carcinoma exhibiting diastase-resistant PAS-positive globular cytoplasmic inclusions and rhabdoid features arising in adult polycystic kidney disease: a case report. Int J Surg Pathol. 2004;12:171-177.
13. Shannon BA, Cohen RJ. Rhabdoid differentiation of chromophobe renal cell carcinoma. Pathology. 2003;35:228-230.
14. Tamboli P, Toprani TH, Amin MB, et al. Carcinoma of lung with rhabdoid features. Hum Pathol. 2004;35:8-13.
15. Perez-Montiel MD, Frankel WL, Suster S. Neuro-endocrine carcinomas of the pancreas with rhabdoid features. Am J Surg Pathol. 2003;27:642-649.
16. Amrikachi M, Ro JY, Ordonez NG, Ayala AG. Adenocarcinomas of the gastrointestinal tract with prominent rhabdoid features. Ann Diagn Pathol. 2002; 6:357-363.
17. Albores-Saavedra J, Sharma S. Poorly differentiated follicular thyroid carcinoma with rhabdoid phenotype: a clinicopathologic, immunohistochemical and electron microscopy study of two cases. Mod Pathol. 2001;14:98-104.
18. Guillou L, Wadden C, Coindre JM, Kraus T, Fletcher CD. Proximal-type epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features: clinicopathologic, immunohistochemical and ultrastructural study of a series. Am J Surg Pathol. 1997;21:130-146.
19. Delahunt B. Sarcomatoid renal carcinoma: the final common dedifferentiation pathway of renal epithelial malignancies. Pathology. 1999;31:185-190.
20. Oda H, Nakatsuru Y, Ishikawa T. Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas. Cancer Res. 1995;55:658-662.
21. Gurova KV, Hill JE, Razorenova OV, Chumakov PM, Gudkov AV. p53 pathway in renal cell carcinoma is repressed by a dominant mechanism. Cancer Res. 2004;64:1951-1958.
22. Warburton HE, Brady M, Vlatkovic N, Linehan WM, Parsons K, Boyd MT. p53 regulation and function in renal cell carcinoma. Cancer Res. 2005;65:6498-6503.
23. Stickle NH, Cheng LS, Watson IR, et al. Expression of p53 in renal carcinoma cells is independent of pVHL. Mutat Res. 2005;578:23-32.
24. Nagao T, Gaffey TA, Serizawa H, et al. Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases. Mod Pathol. 2003;16:1265-1272.
25. Miyagi J, Tsuhako K, Kinjo T, Iwamasa T, Hashimoto H, Ishikawa S. Rhabdoid tumour of the lung is a dedifferentiated phenotype of pulmonary adenocarcinoma. Histopathology. 2000;37:37-44.
26. Yilmazbayhan D, Ates LE, Dilege S, Gulluoglu M, Tanju S, Kalayci G. Pulmonary large cell carcinoma with rhabdoid phenotype. Ann Diagn Pathol. 2005;9:223-226.